IL151564A0 - Potassium channel proteins - Google Patents
Potassium channel proteinsInfo
- Publication number
- IL151564A0 IL151564A0 IL15156401A IL15156401A IL151564A0 IL 151564 A0 IL151564 A0 IL 151564A0 IL 15156401 A IL15156401 A IL 15156401A IL 15156401 A IL15156401 A IL 15156401A IL 151564 A0 IL151564 A0 IL 151564A0
- Authority
- IL
- Israel
- Prior art keywords
- kcnb
- potassium channel
- activity
- channel proteins
- modulate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Psychology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18691500P | 2000-03-03 | 2000-03-03 | |
| PCT/US2001/006801 WO2001066741A2 (en) | 2000-03-03 | 2001-03-02 | Kcnb: a novel potassium channel protein |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL151564A0 true IL151564A0 (en) | 2003-04-10 |
Family
ID=22686808
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL15156401A IL151564A0 (en) | 2000-03-03 | 2001-03-02 | Potassium channel proteins |
| IL151564A IL151564A (en) | 2000-03-03 | 2002-09-02 | Potassium channel proteins |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL151564A IL151564A (en) | 2000-03-03 | 2002-09-02 | Potassium channel proteins |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US7462465B2 (xx) |
| EP (1) | EP1266003B1 (xx) |
| JP (2) | JP2004500825A (xx) |
| CN (1) | CN1426468A (xx) |
| AT (1) | ATE538201T1 (xx) |
| AU (2) | AU2001250794B2 (xx) |
| CA (1) | CA2401906C (xx) |
| ES (1) | ES2378417T3 (xx) |
| IL (2) | IL151564A0 (xx) |
| NZ (1) | NZ521205A (xx) |
| WO (1) | WO2001066741A2 (xx) |
| ZA (1) | ZA200206999B (xx) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002367320A1 (en) * | 2001-12-31 | 2003-07-24 | Algos Therapeutics, Inc. | Methods and materials for modulating task-3 |
| WO2005052586A2 (en) * | 2003-11-27 | 2005-06-09 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with potassium channel, subfamily k, member 3 (kcnk3) |
| WO2005075510A1 (en) * | 2004-02-04 | 2005-08-18 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with potassium channel, subfamily k, member 9 (kcnk9) |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2744730B1 (fr) | 1996-02-08 | 1998-04-17 | Centre Nat Rech Scient | Nouvelle famille de canaux potassium de mammifere, leur clonage et leur utilisation notamment pour le criblage de drogues |
| EP1051485A1 (en) | 1998-01-27 | 2000-11-15 | Smithkline Beecham Plc | Trek-1 like two pore potassium channel |
| EP1090118A2 (en) * | 1998-06-26 | 2001-04-11 | Incyte Pharmaceuticals, Inc. | Human signal peptide-containing proteins |
| DE69938667D1 (de) | 1998-11-09 | 2008-06-19 | Centre Nat Rech Scient | Neue familie von säugetier-kaliumkanälen, ihre klonierung und ihre verwendung, besonders für das drogenscreening |
| JP2002542765A (ja) | 1999-03-05 | 2002-12-17 | スミスクライン ビーチャム パブリック リミテッド カンパニー | 新規化合物 |
| US20020137202A1 (en) * | 1999-12-21 | 2002-09-26 | Catherine Burgess | Novel proteins and nucleic acids encoding same |
| WO2001057252A2 (en) | 2000-02-04 | 2001-08-09 | Aeomica, Inc. | Methods and apparatus for high-throughput detection and characterization of alternatively spliced genes |
| EP1381626A2 (en) | 2000-04-06 | 2004-01-21 | Incyte Genomics, Inc. | Human transporters and ion channels |
| WO2002026983A2 (en) | 2000-09-25 | 2002-04-04 | Millennium Pharmaceuticals, Inc. | 56115, a novel human twik potassium channel and uses therefor |
-
2001
- 2001-03-02 EP EP01924111A patent/EP1266003B1/en not_active Expired - Lifetime
- 2001-03-02 ES ES01924111T patent/ES2378417T3/es not_active Expired - Lifetime
- 2001-03-02 AU AU2001250794A patent/AU2001250794B2/en not_active Ceased
- 2001-03-02 IL IL15156401A patent/IL151564A0/xx unknown
- 2001-03-02 AU AU5079401A patent/AU5079401A/xx active Pending
- 2001-03-02 NZ NZ521205A patent/NZ521205A/en unknown
- 2001-03-02 CA CA2401906A patent/CA2401906C/en not_active Expired - Lifetime
- 2001-03-02 WO PCT/US2001/006801 patent/WO2001066741A2/en active IP Right Grant
- 2001-03-02 JP JP2001565895A patent/JP2004500825A/ja active Pending
- 2001-03-02 US US09/798,584 patent/US7462465B2/en not_active Expired - Fee Related
- 2001-03-02 CN CN01808748A patent/CN1426468A/zh active Pending
- 2001-03-02 AT AT01924111T patent/ATE538201T1/de active
-
2002
- 2002-08-30 ZA ZA200206999A patent/ZA200206999B/en unknown
- 2002-09-02 IL IL151564A patent/IL151564A/en not_active IP Right Cessation
-
2008
- 2008-01-03 US US11/968,795 patent/US20080234470A1/en not_active Abandoned
-
2011
- 2011-01-13 JP JP2011005342A patent/JP2011115169A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2004500825A (ja) | 2004-01-15 |
| US7462465B2 (en) | 2008-12-09 |
| IL151564A (en) | 2008-11-03 |
| US20080234470A1 (en) | 2008-09-25 |
| WO2001066741A2 (en) | 2001-09-13 |
| JP2011115169A (ja) | 2011-06-16 |
| WO2001066741A9 (en) | 2003-03-06 |
| WO2001066741A3 (en) | 2002-04-04 |
| CA2401906A1 (en) | 2001-09-13 |
| ES2378417T3 (es) | 2012-04-12 |
| CA2401906C (en) | 2011-07-19 |
| AU2001250794B2 (en) | 2006-03-02 |
| CN1426468A (zh) | 2003-06-25 |
| US20020102676A1 (en) | 2002-08-01 |
| ZA200206999B (en) | 2004-05-31 |
| AU5079401A (en) | 2001-09-17 |
| ATE538201T1 (de) | 2012-01-15 |
| EP1266003B1 (en) | 2011-12-21 |
| NZ521205A (en) | 2005-09-30 |
| EP1266003A2 (en) | 2002-12-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2085502A (en) | Diagnosis and treatment of disease | |
| DE60023936D1 (de) | Methoden zur verwendung von randomisierten zinkfingerprotein-bibliotheken zur identifizierung von genfunktionen | |
| ATE319855T1 (de) | Abspaltbare, nicht-flüchtige moleküle zur massenmarkierung | |
| AU4981101A (en) | Subtilisin variants | |
| WO2003022028A3 (en) | Methods, reagents, kits and apparatus for protein function analysis | |
| FI962247A (fi) | Uudet apoptoosia muuntavat proteiinit, niitä koodaava DNA ja näiden käyttömenetelmät | |
| HK1102197A1 (en) | Hif prolyl hydroxylase activity assay | |
| DK0981630T3 (da) | Polypeptider med prolyldipeptidylaminopeptidaseaktivitet og nukleinsyrer, der koder for samme | |
| DE69937835D1 (de) | Antikörper für apoptosemarker und anwendungsverfahren | |
| DE10195935D2 (de) | Nachweis und Identifikation von Bakteriengruppen | |
| HK1049185A1 (zh) | 可改螢光蛋白 | |
| BR9912455A (pt) | ácidos nucléicos codificadores de proteìnas envolvidas em transdução sensória | |
| TR200200667T2 (tr) | Leu-hirudinin E.coli ile kültür ortamında ayrışarak üretilmesinin sinyal sekansları. | |
| ATE389881T1 (de) | Detektion von kleinen molekülen mit piezo- elektrischem sensor | |
| DE60025704D1 (de) | Das goodpasture-antigen bindende protein | |
| ATE288589T1 (de) | Verfahren zur analyse von proteinen | |
| ATE389018T1 (de) | Cx3c chemokin-gene von säugetieren | |
| IL151564A0 (en) | Potassium channel proteins | |
| DE69734586D1 (de) | Retinoid-metabolisierendes protein | |
| BRPI0001536B8 (xx) | ||
| WO2004070012A3 (en) | Cell-killing molecules and methods of use thereof | |
| WO2001031009A3 (en) | Chandra: a th1-specific gene | |
| BR0108767A (pt) | Adenilciclase recombinante, polinucleotìdeo, vetor, processos para a detecção de atividade proteolìtica de uma molécula e da resistência a um inibidor, de uma molécula com atividade proteolìtica e de identificação de moléculas com atividade proteolìtica sìtio-especìfica, kit de diagnóstico, utilização de uma adenilciclase, e, cepa bacteriana | |
| WO2002081691A3 (en) | Abcg5 and abcg8: compositions and methods of use | |
| EP1241269A3 (en) | Method for detecting REG-like protein and nucleic acids coding therefor |